A methylome-based score to predict survival after regorafenib in recurrent glioblastoma. - Chiesa S; Miele E; Patrizi S; Pedace L; Mazzarella C; Offi M; Martino A; Falchetti ML; Di Monaco G; Russo R; Vinciarelli F; Mastronuzzi A; et al. (Neuro-oncology advances, 2026)